Literature DB >> 10452207

Psychosocial determinants of well-being in gynecologic cancer patients.

M Eisemann1, A Lalos.   

Abstract

The purpose of this study was to investigate the well-being of women with endometrial versus cervical cancer before treatment, and its determinants at 12 to 15 months follow-up. The subjects were interviewed before treatment, then 6 and 12 to 15 months after initiation of treatment. Simultaneously, they completed questionnaires on psychological symptoms and social support. It appeared that well-being at baseline and at the follow-ups were highly correlated. Furthermore, cervical cancer patients reported significantly more symptoms on all occasions. After discriminant function analysis, the following three variables remained in the analysis: (a) well-being before treatment, (b) diagnosis, and (c) children at home. This allowed 81% of the patients to be classified as having a favorable versus an unfavorable outcome. The results of this study highlight the importance of well-being before treatment as a predictor of well-being after treatment. The necessity of individualized intervention measures is warranted.

Entities:  

Mesh:

Year:  1999        PMID: 10452207     DOI: 10.1097/00002820-199908000-00007

Source DB:  PubMed          Journal:  Cancer Nurs        ISSN: 0162-220X            Impact factor:   2.592


  9 in total

1.  Phenotypic and molecular characteristics associated with various domains of quality of life in oncology patients and their family caregivers.

Authors:  Kimberly E Alexander; Bruce A Cooper; Steven M Paul; Patsy Yates; Bradley E Aouizerat; Christine Miaskowski
Journal:  Qual Life Res       Date:  2016-05-09       Impact factor: 4.147

Review 2.  Expanding the scope of nursing research in low resource and middle resource countries, regions, and states focused on cervical cancer prevention, early detection, and control.

Authors:  Sandra Millon Underwood; Edith Ramsay-Johnson; Asante Dean; Jori Russ; Ruth Ivalis
Journal:  J Natl Black Nurses Assoc       Date:  2009-12

3.  Changes in short-term health-related quality of life in women undergoing gynecologic oncologic laparotomy: an associated factor analysis.

Authors:  Lucas Minig; Jorge Iván Vélez; Edward L Trimble; Roberto Biffi; Angelo Maggioni; Diana D Jeffery
Journal:  Support Care Cancer       Date:  2012-08-29       Impact factor: 3.603

4.  Randomized trial results of quality of life comparing whole abdominal irradiation and combination chemotherapy in advanced endometrial carcinoma: A gynecologic oncology group study.

Authors:  Deborah Watkins Bruner; Andrea Barsevick; Chunqiao Tian; Marcus Randall; Robert Mannel; David E Cohn; Joel Sorosky; Nick M Spirtos
Journal:  Qual Life Res       Date:  2006-10-11       Impact factor: 4.147

5.  The impact of cervical cancer and dysplasia: a qualitative, multiethnic study.

Authors:  Kimlin T Ashing-Giwa; Marjorie Kagawa-Singer; Geraldine V Padilla; Judith S Tejero; Evana Hsiao; Rajinder Chhabra; Lucrecia Martinez; M Belinda Tucker
Journal:  Psychooncology       Date:  2004-10       Impact factor: 3.894

6.  Enhancing physical well-being and overall quality of life among underserved Latina-American cervical cancer survivors: feasibility study.

Authors:  Kimlin T Ashing-Giwa
Journal:  J Cancer Surviv       Date:  2008-08-20       Impact factor: 4.442

7.  A prospective investigation of dispositional optimism as a predictor of health-related quality of life in head and neck cancer patients.

Authors:  P J Allison; C Guichard; L Gilain
Journal:  Qual Life Res       Date:  2000       Impact factor: 3.440

8.  Factors associated with quality of life of outpatients with breast cancer and gynecologic cancers and their family caregivers: a controlled study.

Authors:  Abdel W Awadalla; Jude U Ohaeri; Abdullah Gholoum; Ahmed O A Khalid; Hussein M A Hamad; Anila Jacob
Journal:  BMC Cancer       Date:  2007-06-19       Impact factor: 4.430

Review 9.  Quality of life and psychosocial adjustment in gynecologic cancer survivors.

Authors:  Timothy Pearman
Journal:  Health Qual Life Outcomes       Date:  2003-08-20       Impact factor: 3.186

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.